Antimicrobial Susceptibility Survey of Invasive Haemophilus influenzae in the United States in 2016
- PMID: 35536039
- PMCID: PMC9241922
- DOI: 10.1128/spectrum.02579-21
Antimicrobial Susceptibility Survey of Invasive Haemophilus influenzae in the United States in 2016
Abstract
Antibiotics are important for the treatment and prevention of invasive Haemophilus influenzae disease. Reduced susceptibility to clinically relevant drugs, except ampicillin, has been uncommon in the United States. Susceptibility of 700 invasive H. influenzae isolates, collected through population-based surveillance during 2016, was assessed for 15 antibiotics using broth microdilution, according to the CLSI guidelines; a subset of 104 isolates were also assessed for rifampin susceptibility using Etest. Genomes were sequenced to identify genes and mutations known to be associated with reduced susceptibility to clinically relevant drugs. A total of 508 (72.6%) had reduced susceptibility to at least one antibiotic and more than half of the isolates exhibited reduced susceptibility to only one (33.6%) or two (21.6%) antibiotic classes. All tested isolates were susceptible to rifampin, a chemoprophylaxis agent, and <1% (n = 3) of isolates had reduced susceptibility to third generation cephalosporins, which are recommended for invasive disease treatment. In contrast, ampicillin resistance was more common (28.1%) and predominantly associated with the detection of a β-lactamase gene; 26.2% of isolates in the collection contained either a TEM-1 or ROB-1 β-lactamase gene, including 88.8% of ampicillin-resistant isolates. β-lactamase negative ampicillin-resistant (BLNAR) isolates were less common and associated with ftsI mutations; resistance to amoxicillin-clavulanate was detected in <2% (n = 13) of isolates. The proportion of reduced susceptibility observed was higher among nontypeable H. influenzae and serotype e than other serotypes. US invasive H. influenzae isolates remain predominantly susceptible to clinically relevant antibiotics except ampicillin, and BLNAR isolates remain uncommon. IMPORTANCE Antibiotics play an important role for the treatment and prevention of invasive Haemophilus influenzae disease. Antimicrobial resistance survey of invasive H. influenzae isolates collected in 2016 showed that the US H. influenzae population remained susceptible to clinically relevant antibiotics, except for ampicillin. Detection of approximately a quarter ampicillin-resistant and β-lactamase containing strains demonstrates that resistance mechanisms can be acquired and sustained within the H. influenzae population, highlighting the continued importance of antimicrobial resistance surveillance for H. influenzae to monitor susceptibility trends and mechanisms of resistance.
Keywords: Haemophilus influenzae; antimicrobial susceptibility; invasive disease.
Conflict of interest statement
The authors declare no conflict of interest.
Similar articles
-
Antimicrobial resistance among Haemophilus influenzae isolates responsible for lower respiratory tract infections in Poland, 2005-2019.Eur J Clin Microbiol Infect Dis. 2022 Jun;41(6):961-969. doi: 10.1007/s10096-022-04457-w. Epub 2022 May 18. Eur J Clin Microbiol Infect Dis. 2022. PMID: 35585442
-
Low beta-lactamase-negative ampicillin-resistant Haemophilus influenzae strains are best detected by testing amoxicillin susceptibility by the broth microdilution method.Antimicrob Agents Chemother. 2008 Jul;52(7):2407-14. doi: 10.1128/AAC.00214-08. Epub 2008 Apr 28. Antimicrob Agents Chemother. 2008. PMID: 18443129 Free PMC article.
-
Serotypes, antimicrobial susceptibility, and beta-lactam resistance mechanisms of clinical Haemophilus influenzae isolates from Bulgaria in a pre-vaccination period.Scand J Infect Dis. 2013 Feb;45(2):81-7. doi: 10.3109/00365548.2012.710854. Epub 2012 Sep 19. Scand J Infect Dis. 2013. PMID: 22992181
-
Revisiting mutational resistance to ampicillin and cefotaxime in Haemophilus influenzae.Genome Med. 2024 Dec 4;16(1):140. doi: 10.1186/s13073-024-01406-4. Genome Med. 2024. PMID: 39633433 Free PMC article.
-
Haemophilus influenzae resistance in Latin America: systematic review of surveillance data.Microb Drug Resist. 2001 Winter;7(4):403-11. doi: 10.1089/10766290152773419. Microb Drug Resist. 2001. PMID: 11822780
Cited by
-
Antibiotic Resistance of Haemophilus influenzae in Nasopharyngeal Carriage of Children with Acute Otitis Media and in Middle Ear Fluid from Otorrhea.Antibiotics (Basel). 2023 Nov 8;12(11):1605. doi: 10.3390/antibiotics12111605. Antibiotics (Basel). 2023. PMID: 37998807 Free PMC article.
-
Immunological efficiency of Haemophilus influenzae type b polyribosyl ribitol phosphate combined with detoxified lipooligosaccharide in a rabbit model.Iran J Microbiol. 2025 Feb;17(1):106-112. doi: 10.18502/ijm.v17i1.17807. Iran J Microbiol. 2025. PMID: 40330053 Free PMC article.
-
Prevalence of piperacillin/tazobactam resistance in invasive Haemophilus influenzae in Germany.JAC Antimicrob Resist. 2023 Dec 28;6(1):dlad148. doi: 10.1093/jacamr/dlad148. eCollection 2024 Feb. JAC Antimicrob Resist. 2023. PMID: 38161964 Free PMC article.
-
Imipenem heteroresistance but not tolerance in Haemophilus influenzae during chronic lung infection associated with chronic obstructive pulmonary disease.Front Microbiol. 2023 Dec 20;14:1253623. doi: 10.3389/fmicb.2023.1253623. eCollection 2023. Front Microbiol. 2023. PMID: 38179447 Free PMC article.
-
Antibiotic Susceptibility and Molecular Typing of Invasive Haemophilus influenzae Isolates, with Emergence of Ciprofloxacin Resistance, 2017-2021, Italy.Microorganisms. 2023 Jan 26;11(2):315. doi: 10.3390/microorganisms11020315. Microorganisms. 2023. PMID: 36838281 Free PMC article.
References
-
- MacNeil JR, Cohn AC, Farley M, Mair R, Baumbach J, Bennett N, Gershman K, Harrison LH, Lynfield R, Petit S, Reingold A, Schaffner W, Thomas A, Coronado F, Zell ER, Mayer LW, Clark TA, Messonnier NE. 2011. Current epidemiology and trends in invasive Haemophilus influenzae disease–United States, 1989–2008. Clin Infect Dis 53:1230–1236. doi: 10.1093/cid/cir735. - DOI - PubMed
-
- AAP Committee on Infectious Diseases. 2021. Red Book: 2021 Report of the Committee on Infectious Diseases, 32nd Edition.
-
- CDC. 2018. Active Bacterial Core Surveillance Report, Emerging Infections Program Network, Haemophilus influenza 2018, on Centers for Disease Control and Prevention. https://www.cdc.gov/abcs/reports-findings/survreports/hib18.pdf.
-
- Soeters HM, Blain A, Pondo T, Doman B, Farley MM, Harrison LH, Lynfield R, Miller L, Petit S, Reingold A, Schaffner W, Thomas A, Zansky SM, Wang X, Briere EC. 2018. Current epidemiology and trends in invasive Haemophilus influenzae disease–United States, 2009–2015. Clin Infect Dis 67:881–889. doi: 10.1093/cid/ciy187. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
Miscellaneous